]. Gines, P. Schrier, R. Wiesner, R. Edwards, E. Freeman et al., Renal failure in cirrhosis Model for end-stage liver disease (MELD) and allocation of donor livers A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Re-weighting the model for endstage liver disease score components Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations Review article: renal function assessment in cirrhosis -difficulties and alternative measurements Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine, N Engl J Med Gastroenterology Hepatology Gastroenterology Liver Transpl Aliment Pharmacol Ther Hepatology Liver Transpl Scand J Clin Lab Invest, vol.361124311351026591672, issue.1, pp.1279-9091, 2000.

G. Filler, A. Bokenkamp, W. Hofmann, L. Bricon, T. Martinez-bru et al., Cystatin C as a marker of GFR???history, indications, and future research, Clinical Biochemistry, vol.38, issue.1, pp.1-8, 2005.
DOI : 10.1016/j.clinbiochem.2004.09.025

D. J. Newman, H. Thakkar, R. G. Edwards, M. Wilkie, T. White et al., Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine, Kidney International, vol.47, issue.1, pp.312-330, 1995.
DOI : 10.1038/ki.1995.40

U. Poge, T. Gerhardt, B. Stoffel-wagner, H. U. Klehr, T. Sauerbruch et al., Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients, Nephrology Dialysis Transplantation, vol.21, issue.3, pp.660-664, 2006.
DOI : 10.1093/ndt/gfi305

E. Xirouchakis, L. Marelli, E. Cholongitas, P. Manousou, V. Calvaruso et al., Comparison of Cystatin C and Creatinine-based Glomerular Filtration Rate Formulas with 51Cr-EDTA Clearance in Patients with Cirrhosis, Clinical Journal of the American Society of Nephrology, vol.6, issue.1, pp.84-92, 2011.
DOI : 10.2215/CJN.03400410

A. S. Levey, L. A. Stevens, C. H. Schmid, Y. L. Zhang, A. F. Castro et al., A New Equation to Estimate Glomerular Filtration Rate, Annals of Internal Medicine, vol.150, issue.9, pp.604-616, 2009.
DOI : 10.7326/0003-4819-150-9-200905050-00006

L. A. Inker, C. H. Schmid, H. Tighiouart, J. H. Eckfeldt, H. I. Feldman et al., Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C, New England Journal of Medicine, vol.367, issue.1, pp.20-29, 2012.
DOI : 10.1056/NEJMoa1114248

M. K. Nadim, R. S. Sung, C. L. Davis, K. A. Andreoni, S. W. Biggins et al., Simultaneous Liver-Kidney Transplantation Summit: Current State and Future Directions, American Journal of Transplantation, vol.18, issue.Suppl 1, pp.2901-2909, 2012.
DOI : 10.1111/j.1600-6143.2012.04190.x

C. Francoz, D. Glotz, R. Moreau, F. Durand, A. M. Allen et al., All rights reserved Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate Chronic renal failure after transplantation of a nonrenal organ Predictive factors for chronic renal failure one year after orthotopic liver transplantation Chronic kidney disease after nonrenal solid-organ transplantation Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation [24]. Levey A S. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American journal of kidney diseases: the official journal of the National Kidney Foundation Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias First certified reference material for cystatin C in human serum ERM-DA471/IFCC Performance in Measurement of Serum Cystatin C by Laboratories Participating in the College of American Pathologists 2014 CYS Survey Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation Effects of renal impairment on liver transplantation Risk factors for acute renal failure requiring dialysis after liver transplantation Prognostic Value of Preoperatively Obtained Clinical and Laboratory Data in Predicting Survival Following Orthotopic Liver Transplantation Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation Impact of pretransplant renal function on survival after liver transplantation, Chronic kidney disease as a global public health problem: approaches and initiatives -a position statement from Kidney Disease Improving Global Outcomes, pp.605-13286, 1986.

K. Boudjema, C. Camus, F. Saliba, Y. Calmus, E. Salame et al., All rights reserved Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension Chronic kidney disease stage progression in liver transplant recipients, [42]. Durand F. Hot-topic debate on kidney function: renal-sparing approaches are beneficial, pp.965-761886, 2000.

K. and K. Disease, Outcomes Quality Initiative; BMI, body mass index; HCC, hepatocellular carcinoma; INR, international normalized ratio; MELD, model for end-stage liver disease. All population KDOQI 1 KDOQI, pp.2-3